Impact of Decipher Biopsy Testing on Clinical Outcomes in Localized Prostate Cancer in a Prospective Statewide Collaborative

BACKGROUND: Decipher Biopsy is a commercially-available gene expression classifier used in risk-stratification of newly diagnosed prostate cancer (PCa). Currently, there are no prospective data evaluating its clinical utility. We seek to assess the clinical utility of Decipher Biopsy in localized PC...

Descripción completa

Detalles Bibliográficos
Autores principales: Vince, Randy A., Jiang, Ralph, Qi, Ji, Tosoian, Jeffrey J., Takele, Rebecca, Feng, Felix Y., Linsell, Susan, Johnson, Anna, Shetty, Sughand, Hurley, Patrick, Miller, David C., George, Arvin, Ghani, Khurshid, Sun, Fionna, Seymore, Mariana, Dess, Robert T, Jackson, William C, Schipper, Matthew, Spratt, Daniel E., Morgan, Todd M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770695/
https://www.ncbi.nlm.nih.gov/pubmed/34285350
http://dx.doi.org/10.1038/s41391-021-00428-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770695/
https://www.ncbi.nlm.nih.gov/pubmed/34285350
http://dx.doi.org/10.1038/s41391-021-00428-y

Ejemplares similares